GLP-1 weight loss drugs are still far from cheap, but some of the prices keep dropping. Novo Nordisk is now offering people who pay out of pocket a steep discount for select doses of Ozempic and ...
Novo Nordisk offers diabetes drug Ozempic for less than half the price for cash-paying U.S. patients
Novo Nordisk said it now offers cash-paying U.S. patients its blockbuster diabetes treatment Ozempic for less than half its monthly list price through multiple platforms. Patients can pay $499 in cash ...
Competition is heating up in the GLP-1 space.
People who are prescribed Ozempic to treat type 2 diabetes, but whose insurance does not cover it, or who don’t have insurance, will be able to buy the medication at a lower cost. Novo Nordisk ...
Aug 18 (Reuters) - Novo Nordisk (NOVOb.CO), opens new tab said on Monday it was offering its diabetes drug Ozempic for $499 per month to eligible cash-paying patients with type 2 diabetes in the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results